Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

• click to rate

  Posted by Two Blokes Jun 6 - Filed in Stock - 3 views
  
  Nantahala Capital Management, Stonepine Capital Management, Aytu Management, and New Institutional Shareholders Lead Financing. DENVER, CO / ACCESS Newswire / June 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced the pricing of an upsized public offering of 9,600,000 shares of common stock (or prefunded warrants in lieu thereof) at an effective public offering price of $1.50.